Trinity Biotech (TRIB) Gains from Investment Securities (2012 - 2016)

Trinity Biotech (TRIB) has reported Gains from Investment Securities for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2016.

• Quarterly Gains from Investment Securities changed 0.0% year-over-year to $15000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $36000.0 (up 105.45% YoY) and the FY2022 annual result came in at $2000.0, up 300.0% from the prior year.
• Gains from Investment Securities was little changed at $15000.0 in Q4 2016 per TRIB's latest filing, from $15000.0 in the prior quarter.
• Over the last five years, Gains from Investment Securities for TRIB reached as high as $15000.0 in Q4 2015 and fell as low as $1000.0 in Q4 2013.
• A 4-year average of $9000.0 and a median of $10000.0 in 2012 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2013 — Gains from Investment Securities sank 80.0% — and 2016, when it changed 0.0%.
• Year by year, Gains from Investment Securities stood at $5000.0 in 2012, then plunged by 80.0% to $1000.0 in 2013, then surged by 1400.0% to $15000.0 in 2015, then changed by 0.0% to $15000.0 in 2016.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $15000.0, $15000.0, and $1000.0 for Q4 2016, Q4 2015, and Q4 2013 respectively.